Phase II trial of CX 4945 in combination with gemcitabine and carboplatin in patients with ovarian cancer.
Phase of Trial: Phase II
Latest Information Update: 13 Jun 2011
At a glance
- Drugs Carboplatin; Gemcitabine; Silmitasertib
- Indications Ovarian cancer
- Focus Therapeutic Use
- 13 Jun 2011 New trial record